Acetyl Empagliflozin Furanose Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Acetyl Empagliflozin Furanose Impurity

● In Stock

Catalogue No.:VE0029095
CAS No.:N/A
Mol. Formula:C31H35ClO11
Mol. Weight:619.05 g/mol

Additional information on

Parent drug

Empagliflozin

IUPAC Name

(3S,4S,5R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-5-((S)-1,2-diacetoxyethyl)tetrahydrofuran-3,4-diyl diacetate

Smiles

ClC1=C(CC2=CC=C(O[C@H]3CCOC3)C=C2)C=C(C4O[C@H]([C@H](COC(C)=O)OC(C)=O)[C@H](OC(C)=O)[C@H]4OC(C)=O)C=C1

InChI

InChI=1S/C31H35ClO11/c1-17(33)38-16-27(39-18(2)34)29-31(41-20(4)36)30(40-19(3)35)28(43-29)22-7-10-26(32)23(14-22)13-21-5-8-24(9-6-21)42-25-11-12-37-15-25/h5-10,14,25,27-31H,11-13,15-16H2,1-4H3/t25-,27?,28?,29+,30?,31?/m0/s1

Description

Acetyl Empagliflozin Furanose Impurity is a process-related and/or degradative analog of empagliflozin distinguished by O-acetylation of the furanose-derived glycosidic scaffold. With molecular formula C31H35ClO11 and molecular weight 619.05 g/mol, it contains the aryl chlorinated C-aryl glucoside core and an additional acetate functionality that can arise from incomplete deprotection, acetyl transfer, or downstream transformation of protected intermediates. Its structural assessment is relevant to impurity profiling under ICH Q3A/Q3B. Trace-level measurement typically requires LC-MS/MS or high-resolution LC-MS, supported by orthogonal HPLC-UV or NMR characterization for isomer discrimination.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url